1. |
Mattiuzzi C, Lippi G. Current cancer epidemiology. J Epidemiol Glob Health, 2019, 9(4): 217-222.
|
2. |
Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol, 2019, 14(1): 26-38.
|
3. |
Song Z, Wu Y, Yang J, et al. Progress in the treatment of advanced gastric cancer. Tumour Biol, 2017, 39(7): 1010428317714626.
|
4. |
Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 2010, 127(12): 2893-2917.
|
5. |
Fugazzola P, Ansaloni L, Sartelli M, et al. Advanced gastric cancer: the value of surgery. Acta Biomed, 2018, 89(8-S): 110-116.
|
6. |
Lordick F, Terashima M. Gastric cancer adjuvant therapy. Best Pract Res Clin Gastroenterol, 2016, 30(4): 581-591.
|
7. |
Johnston FM, Beckman M. Updates on management of gastric cancer. Curr Oncol Rep, 2019, 21(8): 67.
|
8. |
Son T, Sun J, Choi S, et al. Multi-institutional validation of the 8th AJCC TNM staging system for gastric cancer: Analysis of survival data from high-volume Eastern centers and the SEER database. J Surg Oncol, 2019, 120(4): 676-684.
|
9. |
Lin JX, Desiderio J, Lin JP, et al. Multicenter validation study of the American Joint Commission on Cancer (8th Edition) for Gastric Cancer: Proposal for a simplified and improved TNM staging system. J Cancer, 2020, 11(12): 3483-3491.
|
10. |
Qiu MZ, Wang ZX, Zhou YX, et al. Proposal for a new TNM stage based on the 7th and 8th American Joint Committee on Cancer pTNM Staging Classification for Gastric Cancer. J Cancer, 2018, 9(19): 3570-3576.
|
11. |
Agnes A, Biondi A, Cananzi FM, et al. Ratio-based staging systems are better than the 7th and 8th editions of the TNM in stratifying the prognosis of gastric cancer patients: A multicenter retrospective study. J Surg Oncol, 2019, 119(7): 948-957.
|
12. |
Lee YC, Yang PJ, Zhong Y, et al. Lymph node ratio-based staging system outperforms the seventh AJCC system for gastric cancer: validation analysis with National Taiwan University Hospital Cancer Registry. Am J Clin Oncol, 2017, 40(1): 35-41.
|
13. |
Attaallah W, Uprak K, Gunal O, et al. Prognostic impact of the metastatic lymph node ratio on survival in gastric cancer. Indian J Surg Oncol, 2016, 7(1): 67-72.
|
14. |
Hou Y, Wang X, Chen J. Prognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer. World J Surg Oncol, 2018, 16(1): 198.
|
15. |
Chen Y, Li C, Du Y, et al. Prognostic and predictive value of metastatic lymph node ratio in stage Ⅲ gastric cancer after D2 nodal dissection. Oncotarget, 2017, 8(41): 70841-70846.
|
16. |
Chevallay M, Bollschweiler E, Chandramohan SM, et al. Cancer of the gastroesophageal junction: a diagnosis, classification, and management review. Ann N Y Acad Sci, 2018, 1434(1): 132-138.
|
17. |
Hashimoto T, Kurokawa Y, Mori M, et al. Surgical treatment of gastroesophageal junction cancer. J Gastric Cancer, 2018, 18(3): 209-217.
|
18. |
Fock KM. Review article: the epidemiology and prevention of gastric cancer. Aliment Pharmacol Ther, 2014, 40(3): 250-260.
|
19. |
Soerjomataram I, Lortet-Tieulent J, Parkin DM, et al. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet, 2012, 380(9856): 1840-1850.
|
20. |
Ilson DH. Advances in the treatment of gastric cancer. Curr Opin Gastroenterol, 2017, 33(6): 473-476.
|
21. |
Yamashita K, Hosoda K, Ema A, et al. Lymph node ratio as a novel and simple prognostic factor in advanced gastric cancer. Eur J Surg Oncol, 2016, 42(9): 1253-1260.
|
22. |
中国抗癌协会胃癌专业委员会, 中华医学会肿瘤学分会胃肠学组, 中国医师协会外科医师分会肿瘤外科医师委员会. 胃癌根治术标本规范淋巴结送检及操作中国专家共识 (2019 版). 中国实用外科杂志, 2019, 39(9): 881-889.
|
23. |
高欣欣, 王新. 影响胃癌患者预后的独立危险因素研究进展. 肿瘤预防与治疗, 2016, 29(2): 123-127.
|
24. |
Bilici A, Selcukbiricik F, Seker M, et al. Prognostic significance of metastatic lymph node ratio in patients with pN3 gastric cancer who underwent curative gastrectomy. Oncol Res Treat, 2019, 42(4): 209-216.
|
25. |
Huang CM, Lin JX, Zheng CH, et al. Prognostic impact of metastatic lymph node ratio on gastric cancer after curative distal gastrectomy. World J Gastroenterol, 2010, 16(16): 2055-2060.
|
26. |
Tokgoz S, Bugdayci Basal F. The prognostic effect of metastatic lymph node ratio in operated gastric cancer patients. J Coll Physicians Surg Pak, 2020, 30(10): 1035-1040.
|
27. |
Wohnrath DR, Araujo RLC. Positive node-ratio in curative-intent treatment for gastric cancer is a strong independent prognostic factor for 5-year overall survival. J Surg Oncol, 2020, 121(5): 777-783.
|
28. |
Komatsu S, Ichikawa D, Nishimura M, et al. Evaluation of prognostic value and stage migration effect using positive lymph node ratio in gastric cancer. Eur J Surg Oncol, 2017, 43(1): 203-209.
|